Generic competition · all medicines · read 12 November 2026
Is there a generic of Latanoprost; Netarsudil Dimesylate, and who makes it?
Latanoprost; Netarsudil Dimesylate appears in 1 dosage-form group in the FDA Orange Book as of 12 November 2026, with no generic maker listed as marketed. 1 group has a brand listed as marketed and no generic listed as marketed. The data does not state why, and it does not state that one is coming. This is the Orange Book's listing, not a forecast.
Method designed and maintained by Vincent Wesley Couey (ORCID 0009-0005-6869-308X). Data compiled automatically from the Orange Book data files, downloaded 12 November 2026. How these pages are made
- Latanoprost; Netarsudil Dimesylate appears in 1 dosage-form group in the FDA Orange Book as of 12 November 2026, with no generic maker listed as marketed.
- 1 group has a brand listed as marketed and no generic listed as marketed. The data does not state why, and it does not state that one is coming.
- Patents and exclusivities are shown as listed by the application holder; the Orange Book does not rule on them, and a listed patent is not a statement that a generic is blocked. This says nothing about price, supply or quality.
Solution/Drops, Ophthalmic
Brand listed, no generic listed as marketed
Brand listed as marketed: Rocklatan. No generic is listed as marketed.
Patents and exclusivities still listed
- 27 January 2030Patent 10174017 drug substance
- 27 January 2030Patent 11618748
- 27 January 2030Patent 10654844 drug substance
- 27 January 2030Patent 11028081
- 10 November 2030Patent 8394826 drug substance
- 14 March 2034Patent 9993470 drug substance
- 14 March 2034Patent 9931336 drug substance
- 14 March 2034Patent 10588901 drug substance
4 more patents are listed.
US Food and Drug Administration, Orange Book data files, downloaded 12 November 2026. A listed patent is not a ruling that a generic is blocked, and no figure here says anything about price, supply or quality. Check the Orange Book.
What do pharmacies pay for Latanoprost; Netarsudil Dimesylate?
The CMS NADAC survey tracks what pharmacies pay to acquire Latanoprost; Netarsudil Dimesylate: 1 product with year-end prices from 2013 to 2026. See the acquisition cost history on RxGrab. It is a pharmacy cost, not a retail price, and this page does not say how it relates to the number of makers listed above.
Where can you go from this result?
Open it in the check to search another medicine, or see every brand with no generic listed. The FDA explains generic approval in how generic drugs are approved and the FDA generic drug facts, and the Orange Book itself is the FDA Orange Book. To check what is available now, ask your pharmacist, and see the FDA drug shortages page.